Scientists at Virginia Tech are revolutionizing depression treatment by tapping into how the brain processes rewards. Their ...

A new study published in Psychological Medicine sheds light on how specific depression symptoms are related to decisions ...

People with bipolar I disorder have had at least one manic episode preceded or followed by hypomanic or major depressive ...

YORK, Pa. — Here are the top health headlines for the week of Jan. 19, 2025. A nasal spray derived from ketamine gets federal clearance to help some people treat depression. The Federal Drug ...

On the company’s Q4 earnings call where an eyepopping $88.8 billion in full-year sales were revealed, leaders shifted focus ...

Johnson & Johnson has announced a major breakthrough in mental health treatment. The Food and Drug Administration (FDA) has approved Spravato, a novel nasal spray, for the standalone treatment of ...

A nasal spray therapy for treatment-resistant major depressive disorder (MDD) has now been approved by the Food and Drug ...

If you’ve been diagnosed with major depressive disorder, seasonal affective depression or any other type of depression, your ...

The largest, most ethnically diverse, study of its kind has flagged hundreds of genetic variants that play a role in ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

Using computational models, the researchers studied how the brain's reward-learning system functions in those with depression, especially among individuals experiencing anhedonia, the inability to ...

The U.S. Food and Drug Administration has approved a nasal spray that is known to help treat depression.